Literature DB >> 17299016

T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.

Shelley L Hyman1, Deepak S Gill, Edwin Arthur Shores, Adam Steinberg, Kathryn N North.   

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is a single gene disorder associated with a high frequency of cognitive deficits and a complex cognitive phenotype. These cognitive deficits have been associated with focal areas of high signal intensity on T2 weighted MRI images but the relationship remains controversial.
METHOD: A cohort of 76 children with NF1 and 45 unaffected sibling controls (aged 8-16 years) underwent extensive neuropsychological assessment, with the NF1 children having MRI examinations.
RESULTS: The presence or number of T2 hyperintensities (T2H) was not associated with cognitive dysfunction. However, the location of discrete (well circumscribed) T2H in the thalamus was associated with severe and generalised cognitive impairment. More diffuse lesions in the thalamus were also associated with reductions in IQ but the effects were less marked compared with the discrete lesions. Comparing children with NF1 to their unaffected siblings revealed more subtle effects of the lesions on cognitive ability.
CONCLUSIONS: T2H cannot be used in general as a radiological marker for cognitive deficits in children with NF1; however, lesions in the thalamus are strongly associated with cognitive impairment. It is possible that lesions in the thalamus in conjunction with more general thalamic hypometabolism may compound the level of thalamic dysfunction, resulting in cognitive deficits well beyond those produced by T2H in other regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299016      PMCID: PMC2117545          DOI: 10.1136/jnnp.2006.108134

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Magnetic resonance imaging lesion analysis in neurofibromatosis type 1.

Authors:  F J DiMario; G Ramsby
Journal:  Arch Neurol       Date:  1998-04

2.  Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.

Authors:  S L Hyman; D S Gill; E A Shores; A Steinberg; P Joy; S V Gibikote; K N North
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

3.  The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

Authors:  Shelley L Hyman; Arthur Shores; Kathryn N North
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

Review 4.  Neurofibromatosis type 1.

Authors:  K North
Journal:  Am J Med Genet       Date:  2000

5.  Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.

Authors:  Shelley L Hyman; E Arthur Shores; Kathryn N North
Journal:  Dev Med Child Neurol       Date:  2006-12       Impact factor: 5.449

6.  Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.

Authors:  R G Steen; J S Taylor; J W Langston; J O Glass; V R Brewer; W E Reddick; R Mages; E K Pivnick
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

7.  Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging.

Authors:  P Y Wang; W E Kaufmann; C W Koth; M B Denckla; P B Barker
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

8.  Magnetic resonance imaging evaluation of learning difficulties and incoordination in neurofibromatosis.

Authors:  D W Dunn; K L Roos
Journal:  Neurofibromatosis       Date:  1989

9.  The significance of MRI abnormalities in children with neurofibromatosis.

Authors:  P K Duffner; M E Cohen; F G Seidel; D W Shucard
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

10.  Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.

Authors:  R Feldmann; J Denecke; M Grenzebach; G Schuierer; J Weglage
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

View more
  26 in total

Review 1.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

2.  Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1.

Authors:  Rony Cohen; Tamar Steinberg; Liora Kornreich; Sharon Aharoni; Ayelet Halevy; Avinoam Shuper
Journal:  Eur J Pediatr       Date:  2014-07-16       Impact factor: 3.183

3.  Clinical Images: Imaging Manifestations of Orbital Neurofibromatosis Type 1.

Authors:  James M Milburn; Carlos R Gimenez; Elizabeth Dutweiler
Journal:  Ochsner J       Date:  2016

Review 4.  The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.

Authors:  Maria T Acosta; Carrie E Bearden; F Xavier Castellanos; Xavier F Castellanos; Laurie Cutting; Ype Elgersma; Gerard Gioia; David H Gutmann; Yong-Seok Lee; Eric Legius; Maximillian Muenke; Kathryn North; Luis F Parada; Nancy Ratner; Kim Hunter-Schaedle; Alcino J Silva
Journal:  Am J Med Genet A       Date:  2012-07-20       Impact factor: 2.802

5.  Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.

Authors:  Ivayla Apostolova; Dagmara Niedzielska; Thorsten Derlin; Eva J Koziolek; Holger Amthauer; Benedikt Salmen; Jens Pahnke; Winfried Brenner; Victor F Mautner; Ralph Buchert
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-18       Impact factor: 6.200

6.  Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities.

Authors:  Charlotte Barbier; Camille Chabernaud; Laurent Barantin; Philippe Bertrand; Catherine Sembely; Dominique Sirinelli; Pierre Castelnau; Jean-Philippe Cottier
Journal:  Neuroradiology       Date:  2010-10-20       Impact factor: 2.804

7.  Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.

Authors:  João V Duarte; Maria J Ribeiro; Inês R Violante; Gil Cunha; Eduardo Silva; Miguel Castelo-Branco
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

8.  Evaluation of the basal ganglia in neurofibromatosis type 1.

Authors:  Francesco Nicita; Claudio Di Biasi; Saadi Sollaku; Stefano Cecchini; Vincenzo Salpietro; Angelo Pittalis; Laura Papetti; Fabiana Ursitti; Fiorenza Ulgiati; Anna Maria Zicari; Gian Franco Gualdi; Enrico Properzi; Marzia Duse; Martino Ruggieri; Alberto Spalice
Journal:  Childs Nerv Syst       Date:  2013-07-27       Impact factor: 1.475

9.  Optic nerve tortuosity in children with neurofibromatosis type 1.

Authors:  Joyce Ji; Joshua Shimony; Feng Gao; Robert C McKinstry; David H Gutmann
Journal:  Pediatr Radiol       Date:  2013-05-02

10.  Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI.

Authors:  S Calvez; R Levy; R Calvez; C-J Roux; D Grévent; Y Purcell; K Beccaria; T Blauwblomme; J Grill; C Dufour; F Bourdeaut; F Doz; M P Robert; N Boddaert; V Dangouloff-Ros
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-13       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.